{"id":6279,"date":"2017-07-16T22:23:19","date_gmt":"2017-07-16T22:23:19","guid":{"rendered":"http:\/\/www.firstsightvisioncare.com\/WordPress\/?page_id=6279"},"modified":"2020-04-01T17:30:30","modified_gmt":"2020-04-01T17:30:30","slug":"clinical-research-in-myopia-control","status":"publish","type":"page","link":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/eye-care-services\/clinical-research-in-myopia-control\/","title":{"rendered":"Clinical Research in Myopia Control"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_column_text]Orthokeratology has been studied for many years. Several studies have been done on the safety and effectiveness of ortho-k. Ortho-k has been FDA approved in the United States since 2004. It is a safe and effective treatment for correcting myopia.[\/vc_column_text][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#cccccc&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_tta_accordion gap=&#8221;10&#8243; c_icon=&#8221;chevron&#8221; c_position=&#8221;right&#8221; active_section=&#8221;1&#8243; collapsible_all=&#8221;true&#8221;][vc_tta_section title=&#8221;2015 &#8211; SMART (Stabilizing Myopia by Accelerating Reshaping Technique)&#8221; tab_id=&#8221;1500243100868-bef2b4d5-83a3&#8243;][vc_column_text]This study determined whether orthokeratology lenses can be worn effectively at night to slow progression of myopia in children. Children eight to eleven years old were enrolled in the study. The study compares children wearing soft lenses during the day to children wearing orthokeratology lenses at night.<\/p>\n<p>The outcome of the three-year investigation indicated that myopia progressed at a statistically significantly higher degree in the SCL group as compared to the Ortho K group. There were no significant adverse events in either group from baseline to the three-years. 80% of eyes were successfully fit with CRCL with the first lens fit empirically and 95% of eyes were fit successfully with only one lens change. There was no significant difference between dropout rates during the three-year study between the two groups[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;2013 &#8211; Crimp Study: Corneal Reshaping Influences Myopic Prescription Stability&#8221; tab_id=&#8221;1500243100940-4eea5c9b-1a76&#8243;][vc_column_text]This retrospective study of children younger than age 18 years old provides evidence that ortho-k can reduce the rate of progression of childhood myopia over the long term compared to single vision spectacle lenses. This is one of the major studies that proves that ortho-k can last at least 10 years.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;2012 &#8211; ROMIO: Retardation of Myopia in Orthokeratology (ROMIO)&#8221; tab_id=&#8221;1500243355444-d61a880f-b5a2&#8243;][vc_column_text]On average, patients between ages 6-10 years old subjects wearing ortho-k molds have a slower increase in axial elongation (eyeball length) by 43% compared to subjects wearing spectacle single vision glasses. Younger Children had faster axial elongation and\u00a0may benefit from early orthokeratology intervention.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;2005-2009 &#8211; CLAMP (Contact Lens and Myopia Progression)&#8221; tab_id=&#8221;1500243356723-5f32522f-8733&#8243;][vc_column_text]The CLAMP study began as a way to study the efficacy of using rigid contact lenses to treat myopia in young children as well as determine the mechanism of the treatment if treatment is useful. The study was also used to compare issues of vision and comfort between rigid and soft contact lens wearers. At the end of the study it was found that rigid gas permeable lenses slow the progression of myopia in small children more than soft lenses. However, the decreased refractive error does not also mean that the axial growth is slowed. The study also indicated that the change in corneal curvature is reversible, and is most effective in the first year of use.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;2008 &#8211; CANDY: Controlling Astigmatism and Nearsightedness in Developing Youth&#8221; tab_id=&#8221;1500243537682-cab28740-fec5&#8243;][vc_column_text]This study showed that orthokeratology contact lenses reduced the progression of nearsightedness in kids between 9 and 15. \u00a0The authors of the CANDY study found that the amount myopia in children that wore spectacle single vision lenses increased at a rate of .46D per year while those children wearing the lenses progressed at only .03 diopters per year.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;2007 &#8211; CRAYON: Corneal Reshaping and Yearly Observation of Nearsightedness&#8221; tab_id=&#8221;1500243595069-a98a3454-3024&#8243;][vc_column_text]The CRAYON Study was conducted to compare the growth of the eye between myopic children wearing corneal reshaping (CR) contact lenses and alignment fitted gas permeable (GP) and soft (SCL) contact lenses.\u00a0\u00a0Over two years, the GP group grew, on average, 0.37 mm more than the CR group (p=0.0001) and the SCL group grew, on average, 0.37 mm more than the CR group (p=0.0001).[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;2005 &#8211; Sydney Myopia Study&#8221; tab_id=&#8221;1500243639112-4d47e4b4-5913&#8243;][vc_column_text]This study compare 1,765 six year olds and 2,367 twelve year olds and compares how lifestyle can affect refractive error. This study found that high levels of near work and low levels of outdoor activity had more nearsightedness. On the other hand, children who spent more time outdoors were associated with less myopia.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;2005 &#8211; LORIC (The Longitudinal Ortho-k Research in Children)&#8221; tab_id=&#8221;1500243695776-47bb0c3c-6855&#8243;][vc_column_text]This is another study that was designed to investigate whether or not orthokeratology can effectively reduce and control myopia in young children, by comparing lens use to eyeglasses use. The study monitored growth of axial length, vitreous chamber depth, corneal curvature, and relationships with changes of refractive errors. The study indicated that those who used orthokeratology at night, found that their vision was improved and acceptable throughout the day. The study also showed that those with a higher myopia prescription show a better decline in progression than those without.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;Myopia Control (Houston Study)&#8221; tab_id=&#8221;1500243752330-0523a6ca-b264&#8243;][vc_column_text]This study investigated controlling myopia progression with rigid gas permeable contact lenses versus eyeglasses. Studies showed that those who wore eyeglasses has an increase in myopia of .78 D per year, whereas using gas permeable lenses slowed progression to .42 D per year. The study also showed more axial growth in those that wore eyeglasses than those that wore GP lenses. Thus the decrease in progression of myopia is stronger in GP lenses because of axial length growth reduction and corneal flattening.[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]Orthokeratology has been studied for many years. Several studies have been done on the safety and effectiveness of ortho-k. Ortho-k has been FDA approved in the United States since 2004.&hellip;<\/p>\n","protected":false},"author":1,"featured_media":6114,"parent":5609,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"nf_dc_page":"","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-6279","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Research in Myopia Control - First Sight Vision Care<\/title>\n<meta name=\"description\" content=\"Ortho-k has been FDA approved in the United States since 2004. It is a safe and effective treatment for correcting myopia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Research in Myopia Control - First Sight Vision Care\" \/>\n<meta property=\"og:description\" content=\"Ortho-k has been FDA approved in the United States since 2004. It is a safe and effective treatment for correcting myopia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/\" \/>\n<meta property=\"og:site_name\" content=\"First Sight Vision Care\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/FirstSightVisionCare\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-01T17:30:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.firstsightvisioncare.com\/wp-content\/uploads\/eyeCareServices.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1509\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@fsvc2013\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/\",\"url\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/\",\"name\":\"Clinical Research in Myopia Control - First Sight Vision Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/staging\\\/8330\\\/wp-content\\\/uploads\\\/eyeCareServices.png\",\"datePublished\":\"2017-07-16T22:23:19+00:00\",\"dateModified\":\"2020-04-01T17:30:30+00:00\",\"description\":\"Ortho-k has been FDA approved in the United States since 2004. It is a safe and effective treatment for correcting myopia.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/staging\\\/8330\\\/wp-content\\\/uploads\\\/eyeCareServices.png\",\"contentUrl\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/staging\\\/8330\\\/wp-content\\\/uploads\\\/eyeCareServices.png\",\"width\":1509,\"height\":150,\"caption\":\"Eye Care Services\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/clinical-research-in-myopia-control\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eye Care Services\",\"item\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/eye-care-services\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Research in Myopia Control\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/#website\",\"url\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/\",\"name\":\"First Sight Vision Care\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/#organization\",\"name\":\"First Sight Vision Care\",\"url\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/staging\\\/8330\\\/wp-content\\\/uploads\\\/FSVC_Logo.png\",\"contentUrl\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/staging\\\/8330\\\/wp-content\\\/uploads\\\/FSVC_Logo.png\",\"width\":250,\"height\":167,\"caption\":\"First Sight Vision Care\"},\"image\":{\"@id\":\"https:\\\/\\\/www.firstsightvisioncare.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/FirstSightVisionCare\",\"https:\\\/\\\/x.com\\\/fsvc2013\",\"https:\\\/\\\/www.instagram.com\\\/firstsightvisioncare\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Research in Myopia Control - First Sight Vision Care","description":"Ortho-k has been FDA approved in the United States since 2004. It is a safe and effective treatment for correcting myopia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Research in Myopia Control - First Sight Vision Care","og_description":"Ortho-k has been FDA approved in the United States since 2004. It is a safe and effective treatment for correcting myopia.","og_url":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/","og_site_name":"First Sight Vision Care","article_publisher":"http:\/\/www.facebook.com\/FirstSightVisionCare","article_modified_time":"2020-04-01T17:30:30+00:00","og_image":[{"width":1509,"height":150,"url":"https:\/\/www.firstsightvisioncare.com\/wp-content\/uploads\/eyeCareServices.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@fsvc2013","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/","url":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/","name":"Clinical Research in Myopia Control - First Sight Vision Care","isPartOf":{"@id":"https:\/\/www.firstsightvisioncare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/#primaryimage"},"image":{"@id":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/#primaryimage"},"thumbnailUrl":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-content\/uploads\/eyeCareServices.png","datePublished":"2017-07-16T22:23:19+00:00","dateModified":"2020-04-01T17:30:30+00:00","description":"Ortho-k has been FDA approved in the United States since 2004. It is a safe and effective treatment for correcting myopia.","breadcrumb":{"@id":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/#primaryimage","url":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-content\/uploads\/eyeCareServices.png","contentUrl":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-content\/uploads\/eyeCareServices.png","width":1509,"height":150,"caption":"Eye Care Services"},{"@type":"BreadcrumbList","@id":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/clinical-research-in-myopia-control\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.firstsightvisioncare.com\/"},{"@type":"ListItem","position":2,"name":"Eye Care Services","item":"https:\/\/www.firstsightvisioncare.com\/eye-care-services\/"},{"@type":"ListItem","position":3,"name":"Clinical Research in Myopia Control"}]},{"@type":"WebSite","@id":"https:\/\/www.firstsightvisioncare.com\/#website","url":"https:\/\/www.firstsightvisioncare.com\/","name":"First Sight Vision Care","description":"","publisher":{"@id":"https:\/\/www.firstsightvisioncare.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.firstsightvisioncare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.firstsightvisioncare.com\/#organization","name":"First Sight Vision Care","url":"https:\/\/www.firstsightvisioncare.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.firstsightvisioncare.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-content\/uploads\/FSVC_Logo.png","contentUrl":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-content\/uploads\/FSVC_Logo.png","width":250,"height":167,"caption":"First Sight Vision Care"},"image":{"@id":"https:\/\/www.firstsightvisioncare.com\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/FirstSightVisionCare","https:\/\/x.com\/fsvc2013","https:\/\/www.instagram.com\/firstsightvisioncare"]}]}},"_links":{"self":[{"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/pages\/6279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/comments?post=6279"}],"version-history":[{"count":5,"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/pages\/6279\/revisions"}],"predecessor-version":[{"id":6286,"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/pages\/6279\/revisions\/6286"}],"up":[{"embeddable":true,"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/pages\/5609"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/media\/6114"}],"wp:attachment":[{"href":"https:\/\/www.firstsightvisioncare.com\/staging\/8330\/wp-json\/wp\/v2\/media?parent=6279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}